Penumbra (PEN) Net Cash Flow (2014 - 2026)
Penumbra's (PEN) quarterly Net Cash Flow came in at $54.4 million in Q1 2026, up 6.36% year-on-year from $51.2 million in Q1 2025, and up 140.59% on a QoQ basis from -$134.1 million in Q4 2025.
Penumbra (PEN) Net Cash Flow (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Net Cash Flow data on file, last reported at $54.4 million in Q1 2026.
- On a quarterly basis, Net Cash Flow rose 6.36% year-over-year to $54.4 million in Q1 2026; TTM through Mar 2026 was -$136.1 million, a 188.18% decrease from a year earlier, with the FY2025 full-year figure at -$139.4 million, down 187.62% from the prior year.
- Net Cash Flow for Q1 2026 stood at $54.4 million, up from -$134.1 million in the prior quarter.
- Over the last five years, Net Cash Flow for PEN reached as high as $66.5 million in Q4 2023 and fell as low as -$134.1 million in Q4 2025.
- Historically, Net Cash Flow has averaged $10.7 million across 5 years, with a median of $19.1 million in 2023.
- Across the five-year window, Net Cash Flow surged 323.19% in 2023 and tumbled 1103.06% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at $15.7 million in 2022, then jumped by 323.19% to $66.5 million in 2023, then slumped by 30.45% to $46.2 million in 2024, then slumped by 390.14% to -$134.1 million in 2025, then jumped by 140.59% to $54.4 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were $54.4 million in Q1 2026, -$134.1 million in Q4 2025, and -$100.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | 54.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.43 Mn |
| Mar 31, 2026 | 54.43 Mn |
| Dec 31, 2025 | -134.11 Mn |
| Dec 31, 2025 | -134.11 Mn |
| Sep 30, 2025 | -100.65 Mn |
| Sep 30, 2025 | -100.65 Mn |
| Jun 30, 2025 | 44.18 Mn |
| Jun 30, 2025 | 44.18 Mn |
| Mar 31, 2025 | 51.18 Mn |
| Mar 31, 2025 | 51.18 Mn |
| Dec 31, 2024 | 46.22 Mn |
| Dec 31, 2024 | 46.22 Mn |
| Sep 30, 2024 | -8.37 Mn |
| Sep 30, 2024 | -8.37 Mn |
| Jun 30, 2024 | 65.36 Mn |
| Jun 30, 2024 | 65.36 Mn |
| Mar 31, 2024 | 55.89 Mn |
| Mar 31, 2024 | 55.89 Mn |
| Dec 31, 2023 | 66.46 Mn |
| Dec 31, 2023 | 66.46 Mn |